Jason Camm
Biopharmaceuticals
Chemomab
Israel
Biography
Jason Camm is the Chief Medical Officer at Thiel Capital. He co-leads a team focused on breakthrough life science investments and has experience in medical technologies, biopharmaceuticals, corporate leadership and investment management. Jason currently sits on the board of numerous biotechnology companies as well as the board of Tufts University Friedman school.
Research Interest
Biopharmaceuticals
